IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial
Zhu, Honghu1; Mang, Xiao-hui1; Qin, Yazhen1; Jiang, Hao1; Liu, Dai-Hong1; Chen, Huan1; Jiang, Qian1; Chai, Jun-Yue2; Wang, Li-Ru3; Huang, Xiaojun1
刊名BLOOD
2012-11-16
120期:21
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology
研究领域[WOS]Hematology
语种英语
WOS记录号WOS:000313838900320
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61902
专题北京大学第二临床医学院
北京大学第二临床医学院_血液科
作者单位1.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
2.Beijing 6 Hosp, Beijing, Peoples R China
3.Beijing Rehabil Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Zhu, Honghu,Mang, Xiao-hui,Qin, Yazhen,et al. Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial[J]. BLOOD,2012,120(21).
APA Zhu, Honghu.,Mang, Xiao-hui.,Qin, Yazhen.,Jiang, Hao.,Liu, Dai-Hong.,...&Huang, Xiaojun.(2012).Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial.BLOOD,120(21).
MLA Zhu, Honghu,et al."Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial".BLOOD 120.21(2012).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhu, Honghu]的文章
[Mang, Xiao-hui]的文章
[Qin, Yazhen]的文章
百度学术
百度学术中相似的文章
[Zhu, Honghu]的文章
[Mang, Xiao-hui]的文章
[Qin, Yazhen]的文章
必应学术
必应学术中相似的文章
[Zhu, Honghu]的文章
[Mang, Xiao-hui]的文章
[Qin, Yazhen]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。